Viewing StudyNCT06443944



Ignite Creation Date: 2024-06-16 @ 11:50 AM
Last Modification Date: 2024-10-26 @ 3:31 PM
Study NCT ID: NCT06443944
Status: AVAILABLE
Last Update Posted: 2024-06-05
First Post: 2024-05-30

Brief Title: An Expanded Access Program of Cretostimogene Grenadenorepvec for Treatment of NMIBC for Patients Unresponsive to BCG
Sponsor: CG Oncology Inc
Organization: CG Oncology Inc

Conditions & Keywords Data

Conditions:
Name
Non-Muscle Invasive Bladder Cancer
Urothelial Carcinoma
Urologic Cancer
Bladder Cancer
Keywords:
Name View
Cretostimogene Grenadenorepvec View
Urology View
Bladder Cancer View
Non Muscle Invasive Bladder Cancer View